GGHC
BLUE

Gilder Gagnon Howe & Co’s bluebird bio BLUE Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19
Closed -$11K – 395
2020
Q4 		$11K Sell
19
-34,075
-100% -$21.6M ﹤0.01% 326
2020
Q3 		$23.8M Sell
34,094
-13,188
-28% -$10.3M 0.15% 129
2020
Q2 		$37.4M Buy
47,282
+4,563
+11% +$3.44M 0.29% 91
2020
Q1 		$25.4M Buy
42,719
+3,338
+8% +$3.25M 0.3% 94
2019
Q4 		$44.8M Buy
39,381
+36,929
+1,506% +$40.1M 0.46% 73
2019
Q3 		$2.92M Sell
2,452
-597
-20% -$912K 0.03% 193
2019
Q2 		$5.02M Buy
3,049
+44
+1% +$76.1K 0.05% 173
2019
Q1 		$6.13M Buy
3,005
+1,813
+152% +$3.19M 0.07% 148
2018
Q4 		$1.53M Sell
1,192
-15,677
-93% -$24M 0.02% 198
2018
Q3 		$31.9M Buy
16,869
+6,187
+58% +$12.8M 0.33% 79
2018
Q2 		$21.7M Sell
10,682
-1,121
-9% -$2.56M 0.23% 90
2018
Q1 		$26.1M Buy
11,803
+11,272
+2,123% +$28.7M 0.32% 83
2017
Q4 		$1.23M Buy
+531
New +$1.08M 0.02% 210
2016
Q3 		– Sell
-8,081
Closed -$4.53M – 274
2016
Q2 		$4.53M Sell
8,081
-484
-6% -$274K 0.09% 122
2016
Q1 		$4.71M Sell
8,565
-14,234
-62% -$8.74M 0.09% 115
2015
Q4 		$19M Sell
22,799
-396
-2% -$396K 0.31% 68
2015
Q3 		$25.7M Buy
23,195
+3,112
+15% +$5.67M 0.41% 63
2015
Q2 		$43.8M Buy
20,083
+16,859
+523% +$34.3M 0.58% 48
2015
Q1 		$5.04M Buy
3,224
+2,805
+669% +$3.7M 0.07% 136
2014
Q4 		$498K Buy
419
+95
+29% +$63.5K 0.01% 225
2014
Q3 		$151K Sell
324
-13
-4% -$6K ﹤0.01% 254
2014
Q2 		$169K Buy
+337
New +$108K ﹤0.01% 266

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Gilder Gagnon Howe & Co's BLUE Position: Q1 2021 in Review

Gilder Gagnon Howe & Co sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 19 shares — an estimated $11K sold.

Gilder Gagnon Howe & Co first reported a position in BLUE in Q2 2014 and held it in 22 quarters. The position peaked at $44.8M in Q4 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Gilder Gagnon Howe & Co reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 19 bluebird bio shares in Q1 2021, an estimated $11K.
  • Gilder Gagnon Howe & Co first reported a position in bluebird bio in Q2 2014 and held it in 22 quarters.
  • Gilder Gagnon Howe & Co's bluebird bio position peaked at $44.8M in Q4 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2021, filed 17 May 2021.